Stock comparison
Side-by-side financials for FEMY and DXCM. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
Market cap data is available for the leading company in this comparison.
Market value leader
DXCM
Latest market capitalization comparison.
Revenue leader
DXCM
FEMY: $2.29M vs DXCM: $4.66B.
Profit leader
DXCM
FEMY: -$18.63M vs DXCM: $836.30M.
Margin leader
DXCM
FEMY: -812.3% vs DXCM: 17.9% net margin.
| Metric | FEMY | DXCM |
|---|---|---|
| Market cap | - | $32.81 B |
| US-listed rank | - | #443 |
| Revenue (latest FY) | $2.29M | $4.66B |
| Net income (latest FY) | -$18.63M | $836.30M |
| Net margin | -812.3% | 17.9% |
| P/E (trailing FY) | - | 39.2x |
| SEC filings | 312 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, FEMASYS INC reported $2.29M in revenue while DEXCOM INC reported $4.66B.
Full pages: FEMASYS INC and DEXCOM INC, or browse the full rankings.